"10.1371_journal.pone.0048816","plos one","2012-12-12T00:00:00Z","Elisabetta Pace; Caterina Di Sano; Stefania La Grutta; Maria Ferraro; Giuseppe Albeggiani; Giuseppe Liotta; Serena Di Vincenzo; Carina Gabriela Uasuf; Jean Bousquet; Mark Gjomarkaj","Istituto di Biomedicina e Immunologia Molecolare, Unità di Immunopatologia e Farmacologia Clinica e Sperimentale dellApparato Respiratorio, Consiglio Nazionale delle Ricerche, Palermo, Italy; Environmental Health, ARPA, Palermo, Italy; University Hospital, Montpellier, France","Conceived and designed the experiments: EP. Performed the experiments: CDS MF GA SDV. Analyzed the data: EP. Contributed reagents/materials/analysis tools: CDS MF. Wrote the paper: EP JB MG. Selected patients: SLG GL CGU. Managed biological samples: SLG GL CGU.","EP has received research funds and budesonide from Italchimici. JB has received honoraria for scientific and advisory boards, lectures during meetings, press conferences from Stallergènes, Actelion, Almirall, AstraZeneca, Chiesi, GSK, Merck, MSD, and Novartis. The budesonide used in the present study was provided by Italchimici. AstraZeneca has several patents and markets several budesonide products. There are no other patents, marketed products or products in development to declare. This does not alter the authors adherence to all the PLOS ONE policies on sharing data and materials, as detailed online in the guide for authors.","2012","12","Elisabetta Pace","EP",10,TRUE,1,4,1,3,TRUE,TRUE,FALSE,0,NA,FALSE
